Skip to main content
Premium Trial:

Request an Annual Quote

Eureka Genomics Nets $450K USDA Grant for Bovine Genotyping Assay

NEW YORK (GenomeWeb) – Eureka Genomics said today it has received a $450,000 grant from the US Department of Agriculture to commercialize a next-generation sequencing-based bovine genotyping assay, and that the company plans to raise additional capital from investors to advance new targeted clinical and agricultural assays.

Eureka said will use the grant from USDA's National Institute of Food and Agriculture to commercialize its Sparse Genome Scan (SGS), a platform that produces commercially relevant data currently generated from microarrays at lower cost. The new grant follows a $100,000 NIFA award from 2012, and a related ongoing cooperative research and development agreement with the USDA's Meat Animal Research Center.

The Hercules, Calif.-based company said the SGS is a next-generation genotyping (NGG) technology that can be used in agriculture and research to determine parentage, genetic defects, quantitative traits, and marker-assisted feedlot management. The company said it is already offering genotype testing of barley for traits such as yield, environmental resilience, and nutritional value, and is developing pilot projects for other crops.

Eureka Chief Operating Officer Didier Perez said in a statement that the firm plans to provide a low-cost next-generation genotyping platform targeting the agricultural biotech, clinical, and research markets "in the very near term."

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.